NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 20 filers reported holding NEUROBO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 166 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 166 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 166 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -75.0% | 166 | -87.5% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 1,330 | +58.0% | 0.00% | – |
| Q1 2021 | $4,000 | +100.0% | 842 | +99.5% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 422 | +363.7% | 0.00% | – |
| Q3 2020 | $1,000 | – | 91 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $214,000 | 0.02% |
| UBS Group AG | 1,037 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 371 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 323 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 24,642 | $92,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 728 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 60,792 | $226,000 | 0.00% |
| STATE STREET CORP | 15,878 | $59,000 | 0.00% |
| MORGAN STANLEY | 141 | $0 | 0.00% |